Go Deep
Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 9,269 | -6.7 | 17.79 | 2.40 | 544.74 |
| Oct 2026 | 9,455 | -6.6 | 17.54 | 2.40 | 535.50 |
| Oct 2026 | 9,222 | -6.8 | 17.86 | 2.40 | 545.08 |
| Oct 2026 | 9,897 | -6.3 | 16.95 | 2.40 | 516.20 |
| Oct 2026 | 9,432 | -6.6 | 17.57 | 2.40 | 535.71 |
| Oct 2026 | 9,036 | -6.8 | 18.10 | 2.40 | 551.83 |
| Oct 2026 | 9,071 | -6.8 | 18.06 | 2.40 | 549.05 |
| Oct 2026 | 9,850 | -6.4 | 17.02 | 2.40 | 516.32 |
| Oct 2026 | 9,571 | -6.5 | 17.39 | 2.40 | 529.83 |
Orchestra BioMed Holdings, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 88,000.0 | 110,000.0 | 30,917,000.0 | 861,000.0 |
| Net Profit | -23,755,000.0 | -20,691,000.0 | 6,245,000.0 | -20,828,000.0 |
| EPS | -0.4 | -0.3 | — | -0.4 |
Orchestra BioMed Holdings, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 33,482,000.0 | 2,638,000.0 | 2,760,000.0 | 3,533,000.0 | — |
| Net Profit | -52,701,000.0 | -61,024,000.0 | -49,120,000.0 | -33,608,000.0 | — |
| EPS | -1.1 | -1.7 | -1.5 | -1.1 | — |
Orchestra BioMed Holdings, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 114,857,000.0 | 76,173,000.0 | 95,212,000.0 | 95,572,000.0 | — |
| Total Liabilities | 61,287,000.0 | 43,215,000.0 | 27,169,000.0 | 43,038,000.0 | — |
| Total Equity | 53,570,000.0 | 32,958,000.0 | 68,043,000.0 | 52,534,000.0 | — |
Owes vs Owns
Orchestra BioMed Holdings, Inc. owed $0.83 for every $1 it owned in Jun 2026, up from $0.45 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.83× | 0.53× | 0.57× | 0.29× | 0.45× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Orchestra BioMed Holdings, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 92.7%Fixed assets (tangible) 2.8%Long-term investments 2.2%Other assets 1.9%
How it's funded — Dec 2025
Short-term debt 0.7%Long-term debt 12.4%Payables 5.3%Other liabilities 35.0%Shareholders' equity 46.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 106.5 | 66.8 | 87.6 | 83.8 |
| Receivables | 0.1 | 0.1 | 0.1 | 0.1 |
| Inventory | 0.3 | 0.2 | 0.1 | 0.3 |
| Fixed assets (tangible) | 3.2 | 3.5 | 2.8 | 3.7 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 2.5 | 2.5 | 2.5 | 2.5 |
| Other assets | 2.2 | 3.1 | 2.0 | 5.2 |
| Liabilities & equity | ||||
| Short-term debt | 0.8 | 0.6 | 0.6 | 0.7 |
| Long-term debt | 14.3 | 14.3 | 1.0 | 9.5 |
| Payables | 6.1 | 5.1 | 2.9 | 4.0 |
| Other liabilities | 40.2 | 23.2 | 22.6 | 28.9 |
| Shareholders' equity | 53.6 | 33.0 | 68.0 | 52.5 |
| Net tangible assets | 53.6 | 33.0 | 68.0 | 52.5 |
Orchestra BioMed Holdings, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -48,963,000.0 | -50,558,000.0 | -46,127,000.0 | -29,289,000.0 | — |
| Investing Activities | -26,941,000.0 | 13,089,000.0 | 10,687,000.0 | -64,122,000.0 | — |
| Financing Activities | 88,333,000.0 | 29,171,000.0 | 46,215,000.0 | 103,257,000.0 | — |